학술논문
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Document Type
Letter
Author
Source
In: Leukemia . (Leukemia, April 2024, 38(4):918-922)
Subject
Language
English
ISSN
14765551
08876924
08876924